期刊文献+

Treatment of viral hepatitis in China: better clinical research and improved practice 被引量:4

Treatment of viral hepatitis in China: better clinical research and improved practice
原文传递
导出
摘要 Hepatitis virus infection, especially chronic infection with hepatitis B virus (HBV) and hepatitis C virus (HCV), is a serious issue to global public health. Although the prevalence of HBsAg in the general population has been declined dramatically in China due to universal HBV vaccination in newborns, chronic hepatitis B and hepatitis C are still the main causes of cirrhosis and hepatocellular carcinoma (HCC) that are responsible for a high rate of morbidity and mortality.1'2 HBV- and HCV-related end-stage liver disease are also the leading indications of liver transplantation in China. Hepatitis virus infection, especially chronic infection with hepatitis B virus (HBV) and hepatitis C virus (HCV), is a serious issue to global public health. Although the prevalence of HBsAg in the general population has been declined dramatically in China due to universal HBV vaccination in newborns, chronic hepatitis B and hepatitis C are still the main causes of cirrhosis and hepatocellular carcinoma (HCC) that are responsible for a high rate of morbidity and mortality.1'2 HBV- and HCV-related end-stage liver disease are also the leading indications of liver transplantation in China.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2009年第19期2236-2238,共3页 中华医学杂志(英文版)
关键词 viral hepatitis THERAPEUTICS China ADVANCE viral hepatitis therapeutics China advance
  • 相关文献

参考文献6

二级参考文献32

共引文献2057

同被引文献20

引证文献4

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部